New sponsor
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. filed its first LCA in FY2026 and has 18 filings so far. A sponsorship history this short says little about how it handles a case that goes wrong.
- New positions, FY2026
- 3
- Lifetime filings
- 18
- Worker positions
- 18
- Median offered wage
- $115,000
Positions filed as NEW employment in the latest filed fiscal year — the closest honest read on new people being sponsored.
Labor condition applications across every fiscal year in the corpus.
FY2026 – FY2026
Positions on those applications — NOT people and NOT visas granted. A worker renewed three times counts three times.
Derived at read time from the $5,000 wage bands, across every occupation.
18 disclosed positions
Employer of record
The entity exactly as it appears on the filings. This name is the entity — nothing here is combined with a similarly named company.
- Name as filed
- Sarepta Therapeutics, Inc.
- Address
- 215 First StreetCambridge, MA 02142UNITED STATES OF AMERICA
- Phone
- +1 (617) 274-4000
- Industry (NAICS)
- 325412Pharmaceutical and Medicine Manufacturing
- Point of contact
- Tara ClarkVice President, Global HR Operations & Talent Acquisition
- Declared status
- Neither flag declared on the filings
Filing volume
Filings, worker positions and new-employment positions per fiscal year. Three different measurements, never added together.
| Fiscal year | Filings | Worker positions | New-employment positions |
|---|---|---|---|
| FY2026Oct 2025 – Sep 2026 | 18 | 18 | 3 |
Case status (filings)
| Bucket | Count | Share |
|---|---|---|
| Certified | 3 | 16.7% |
| Certified, then withdrawn | 15 | 83.3% |
Petition type (positions)
| Bucket | Count | Share |
|---|---|---|
| New employment | 3 | 16.7% |
| Continued employment (renewal) | 1 | 5.6% |
| Change of previous employment | 2 | 11.1% |
| Change of employer | 7 | 38.9% |
| Amended petition | 5 | 27.8% |
6% of this employer's petition-type positions are continued employment — the same worker renewed. That is why the headline figure above is new-employment positions rather than filings: an employer renewing the same staff every three years produces the same filing volume as one hiring that many new people, and the two are not the same opportunity.
Open jobs at this employer right now
The filing history is public record. Live postings are the other half, and none are matched to this employer today.
No open postings matched to this employer right now.
Track Sarepta Therapeutics, Inc. while you job hunt. SubmitX watches new postings at sponsors like this one and fills the applications for you.
Get started freeRoles filed
The job title is whatever the employer wrote on the application. Nothing is reclassified, and the wage band is derived from the $5,000 bands rather than read from a stored average.
| Job title as filed | SOC occupation | Filings | Positions | Offered wage, 25th–75th | Prevailing wage level |
|---|---|---|---|---|---|
| Senior Engineer, Gene Therapy Upstream Process Development | 19-1042.00Medical Scientists, Except Epidemiologists | 2 | 2 | $100,625 – $128,750median $111,250 · 9 disclosed | Level II3 of 9 positions |
| Senior Manager, Social Media Engagement | 11-2021.00Marketing Managers | 2 | 2 | $147,500 – $162,500median $150,000 · 2 disclosed | Level II2 of 2 positions |
| Director, Regulatory Affairs CMC | 11-9199.01Regulatory Affairs Managers | 1 | 1 | $196,250 – $198,750median $197,500 · 1 disclosed | Level III1 of 1 positions |
| Lead Engineer, QA IT Validation | 15-1253.00Software Quality Assurance Analysts and Testers | 1 | 1 | $121,250 – $123,750median $122,500 · 1 disclosed | Level III1 of 1 positions |
| Principal Statistical Programmer | 15-2041.00Statisticians | 1 | 1 | $146,250 – $148,750median $147,500 · 1 disclosed | Level IV1 of 1 positions |
| Project Manager, Scientific Business Development | 19-1042.00Medical Scientists, Except Epidemiologists | 1 | 1 | $100,625 – $128,750median $111,250 · 9 disclosed | Level II3 of 9 positions |
| Quality Control Investigations Manager | 11-3051.01Quality Control Systems Managers | 1 | 1 | $126,250 – $128,750median $127,500 · 1 disclosed | Level I1 of 1 positions |
| Research Associate II, Gene Therapy Analytical Development | 19-1042.00Medical Scientists, Except Epidemiologists | 1 | 1 | $100,625 – $128,750median $111,250 · 9 disclosed | Level II3 of 9 positions |
| Research Associate II, In Process Analytics | 19-4021.00Biological Technicians | 1 | 1 | $76,250 – $78,750median $77,500 · 1 disclosed | Level IV1 of 1 positions |
| Research Associate, Gene Therapy | 19-1042.00Medical Scientists, Except Epidemiologists | 1 | 1 | $100,625 – $128,750median $111,250 · 9 disclosed | Level II3 of 9 positions |
| Scientist I, Early Stage Process Development, Gene Therapy | 19-1042.00Medical Scientists, Except Epidemiologists | 1 | 1 | $100,625 – $128,750median $111,250 · 9 disclosed | Level II3 of 9 positions |
| Scientist I, Quality Control | 19-1042.00Medical Scientists, Except Epidemiologists | 1 | 1 | $100,625 – $128,750median $111,250 · 9 disclosed | Level II3 of 9 positions |
| Scientist, Bioinformatics | 19-1029.01Bioinformatics Scientists | 1 | 1 | $106,250 – $108,750median $107,500 · 1 disclosed | Level II1 of 1 positions |
| Senior Engineer, QA Validation and Engineering | 17-2112.02Validation Engineers | 1 | 1 | $101,250 – $103,750median $102,500 · 1 disclosed | Level II1 of 1 positions |
| Senior Manager, Drug Product Manufacturing Science & Tech. | 19-1042.00Medical Scientists, Except Epidemiologists | 1 | 1 | $100,625 – $128,750median $111,250 · 9 disclosed | Level II3 of 9 positions |
| Sr. Principal Engineer, Manufacturing Sciences & Technology | 19-1042.00Medical Scientists, Except Epidemiologists | 1 | 1 | $100,625 – $128,750median $111,250 · 9 disclosed | Level II3 of 9 positions |
Offered wages
Every disclosed offered wage on this employer's certified applications, in $5,000 bands.
25th $102,500 · median $115,000 · 75th $148,750 · 18 disclosed positions
Offered wages from certified Labor Condition Applications, grouped into $5,000 bands. Percentiles are computed from the bands, not from a stored average.
Worksites
Places of employment declared on the applications, ranked by how often they appear.
| Worksite | County | Filings | Share |
|---|---|---|---|
| Cambridge, MASarepta Therapeutics, Inc. | — | 5 | 27.8% |
| Andover, MA100 Federal Street | ANDOVER | 3 | 16.7% |
| Bedford, MA100 Crosby Drive | — | 2 | 11.1% |
| Burlington, MA55 Network Drive | BURLINGTON | 2 | 11.1% |
| Andover, MASarepta Therapeutics, Inc. | CAMBRIDGE CITY | 1 | 5.6% |
| Burlington, MASarepta Therapeutics, Inc. | CAMBRIDGE CITY | 1 | 5.6% |
| Durham, NCSarepta Therapeutics, Inc. | DURHAM | 1 | 5.6% |
| Fuquay Varina, NC2206 Bethpage Dr. | WAKE | 1 | 5.6% |
| Columbus, OHSarepta Therapeutics, Inc | FRANKLIN | 1 | 5.6% |
| Richmond, TX8323 Bristol Summit Way | FORT BEND | 1 | 5.6% |
Outcomes
Derived at read time from the stored approval and denial counts. Nothing here is a stored rate.
- Approval rate
- 100.0%
- Approvals
- 18
- Denials
- 0
- Basis
- DOL decisions
US Department of Labor decisions on the applications, not petition outcomes.
18 adjudicated
Two different measurements. They are never blended into one rate.
A certified-then-withdrawn application was approved and pulled afterwards, so it counts as an approval. An application withdrawn before a decision was never adjudicated and is excluded from the denominator entirely — counting it as a denial would invent a rejection that never happened.
Attorney of record
The agent or attorney named on this employer's applications.
- Attorney
- Grace Alzaibak
- Law firm
- Lee & Novi
- Location
- Centerville, MA
Every figure above is aggregated from Labor Condition Applications published by the US Department of Labor for Sarepta Therapeutics, Inc. as that name appears on the filings. Filing counts are applications, position counts are worker positions on those applications, and neither is a headcount or a count of visas granted. How these pages are built.
Looking for a different company with a similar name? Search every employer — same-named companies are listed separately, with the city and industry that tell them apart.